Answers are grounded in this paper and cite their sources.
TyG-WC is a novel and clinically effective marker for early identifying the risks of prediabetes and diabetes in FDRs of T2DM patients.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: